Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo

We conducted a retrospective cohort study to assess the effect vaccination with the live-attenuated recombinant vesicular stomatitis virus–Zaire Ebola virus vaccine had on deaths among patients who had laboratory-confirmed Ebola virus disease (EVD). We included EVD-positive patients coming to an Eb...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Neil Rupani, Mbong Eta Ngole, J. Austin Lee, Adam R. Aluisio, Monique Gainey, Shiromi M. Perera, Lina Kashibura Ntamwinja, Ruffin Mbusa Matafali, Rigo Fraterne Muhayangabo, Fiston Nganga Makoyi, Razia Laghari, Adam C. Levine, Alexis S. Kearney
Format: Artigo
Idioma:Inglês
Publicat: Centers for Disease Control and Prevention 2022-06-01
Col·lecció:Emerging Infectious Diseases
Matèries:
Ebola virus
recombinant vesicular stomatitis virus–Zaire Ebola virus
rVSV-ZEBOV
viruses
hemorrhagic fever
Ebola
Accés en línia:https://wwwnc.cdc.gov/eid/article/28/6/21-2223_article
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars